Proprietary AI analyst is now available

Mater Dei Valuation Multiples

Discover Mater Dei's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Medica Sur, Auna, Pihlajalinna, Oncoclínicas and more.

Mater Dei Overview

About Mater Dei

Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.


Founded

1980

HQ

Brazil

Employees

3.7K

Financials (LTM)

Revenue: $442M
EBITDA: $97M

EV

$630M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Mater Dei Financials

Mater Dei reported last 12-month revenue of $442M and EBITDA of $97M.

In the same LTM period, Mater Dei generated $137M in gross profit, $97M in EBITDA, and $27M in net income.

Revenue (LTM)


Mater Dei P&L

In the most recent fiscal year, Mater Dei reported revenue of $428M and EBITDA of $108M.

Mater Dei is profitable as of last fiscal year, with gross margin of 30%, EBITDA margin of 25%, and net margin of 5%.

See analyst estimates for Mater Dei
LTMLast FY202320242025202620272028
Revenue$442M$428M$431M$438M$428M
Gross Profit$137M$128M$140M$132M$128M
Gross Margin31%30%33%30%30%
EBITDA$97M$108M$109M($31M)$108M
EBITDA Margin22%25%25%(7%)25%
EBIT Margin17%16%18%15%16%
Net Profit$27M$22M$24M($67M)$22M
Net Margin6%5%5%(15%)5%
Net Debt-$158M---

Financial data powered by Morningstar, Inc.

Mater Dei Stock Performance

Mater Dei has current market cap of $319M, and enterprise value of $630M.

Market Cap Evolution


Mater Dei's stock price is $0.96.

Mater Dei share price decreased by 5.7% in the last 30 days, and increased by 5.8% in the last year.

Mater Dei has an EPS (earnings per share) of $0.07.

See more trading valuation data for Mater Dei
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$630M$319M-3.7%-5.7%-16.3%5.8%$0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Mater Dei Valuation Multiples

Mater Dei trades at 1.4x EV/Revenue multiple, and 6.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Mater Dei

EV / Revenue (LTM)


Mater Dei Financial Valuation Multiples

As of June 5, 2026, Mater Dei has market cap of $319M and EV of $630M.

Mater Dei has a P/E ratio of 12.0x.

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.5x1.5x1.4x1.5x
EV/EBITDA6.5x5.8x5.8x(20.5x)5.8x
EV/EBIT8.4x9.0x8.0x9.3x9.0x
EV/Gross Profit4.6x4.9x4.5x4.8x4.9x
P/E12.0x14.7x13.5x(4.8x)14.7x
EV/FCF17.5x17.0xn/m(47.0x)19.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Mater Dei Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Mater Dei Margins & Growth Rates

Mater Dei grew revenue by 11% but EBITDA decreased by 1% in the last fiscal year.

In the most recent fiscal year, Mater Dei reported gross margin of 30%, EBITDA margin of 25%, and net margin of 5%.

See estimated margins and future growth rates for Mater Dei

Mater Dei Margins

Last FY202420252026202720282029
Gross Margin30%30%30%32%
EBITDA Margin25%(7%)25%22%
EBIT Margin16%15%16%18%
Net Margin5%(15%)5%7%
FCF Margin9%(3%)8%7%

Mater Dei Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth11%2%(2%)11%
Gross Profit Growth20%(6%)(3%)20%
EBITDA Growth(1%)(128%)(453%)(1%)
EBIT Growth22%(15%)3%22%
Net Profit Growth54%(383%)(133%)54%
FCF Growth(6%)526%(340%)8%

Data powered by FactSet, Inc. and Morningstar, Inc.

Mater Dei Operational KPIs

Mater Dei's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Mater Dei's Rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Mater Dei's Rule of X is 51% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Mater Dei
LTMLast FY202320242025202620272028
Rule of 4034%34%---
Bessemer Rule of X53%51%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue-0%0%0%0%
G&A Expenses to Revenue-4%4%4%4%
Opex to Revenue-14%14%15%14%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Mater Dei Competitors

Mater Dei competitors include Medica Sur, Auna, Pihlajalinna, Oncoclínicas, Atrys Health, Humana, Community Health Systems, AirSculpt, MediClin and M1 Kliniken.

Most Mater Dei public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Medica Sur1.1x1.1x4.7x5.2x
Auna1.0x1.0x5.0x4.9x
Pihlajalinna0.6x0.7x3.7x4.0x
Oncoclínicas0.9x0.9x56.4x12.0x
Atrys Health2.8x2.7x19.6x17.8x
Humana0.6x0.6x5.7x5.7x
Community Health Systems0.8x0.9x5.2x7.2x
AirSculpt3.0x3.0x30.3x29.7x

This data is available for Pro users. Sign up to see all Mater Dei competitors and their valuation data.

Start Free Trial

Investments by Mater Dei

Mater Dei has invested in 1 company to date.

Latest investment by Mater Dei was on September 24th 2021. Mater Dei invested in Maria Saúde in their $3M Seed round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Mater Dei

Maria Saúde
Description
Maria Saúde is a São Paulo-headquartered digital health platform delivering virtual consultations, personal doctors, and nutrition plans through its mobile app. The service maintains unified patient records encompassing allergies, test results, and family history, while AI tools validated by physicians handle queries on medications and symptoms. It coordinates appointments via a health concierge and supports users of private insurance and Brazil's SUS public system with specialist referrals nationwide.
HQ CountryBrazil
HQ City
Belo Horizonte
Deal Date24 Sep 2021
RoundSeed
Raised$3M
InvestorsMater Dei
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Mater Dei investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Mater Dei

When was Mater Dei founded?Mater Dei was founded in 1980.
Where is Mater Dei headquartered?Mater Dei is headquartered in Brazil.
How many employees does Mater Dei have?As of today, Mater Dei has over 3K employees.
Who is the CEO of Mater Dei?Mater Dei's CEO is Henrique Moraes Salvador Silva.
Is Mater Dei publicly listed?Yes, Mater Dei is a public company listed on B3.
What is the stock symbol of Mater Dei?Mater Dei trades under MATD3 ticker.
When did Mater Dei go public?Mater Dei went public in 2021.
Who are competitors of Mater Dei?Mater Dei main competitors include Medica Sur, Auna, Pihlajalinna, Oncoclínicas, Atrys Health, Humana, Community Health Systems, AirSculpt, MediClin, M1 Kliniken.
What is the current market cap of Mater Dei?Mater Dei's current market cap is $319M.
What is the current revenue of Mater Dei?Mater Dei's last 12 months revenue is $442M.
What is the current revenue growth of Mater Dei?Mater Dei revenue growth (NTM/LTM) is 13%.
What is the current EV/Revenue multiple of Mater Dei?Current revenue multiple of Mater Dei is 1.4x.
What is the current EBITDA of Mater Dei?Mater Dei's last 12 months EBITDA is $97M.
What is Mater Dei's EBITDA margin?Mater Dei's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of Mater Dei?Current EBITDA multiple of Mater Dei is 6.5x.
What is the current FCF of Mater Dei?Mater Dei's last 12 months FCF is $36M.
What is Mater Dei's FCF margin?Mater Dei's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of Mater Dei?Current FCF multiple of Mater Dei is 17.5x.
How many companies Mater Dei has acquired to date?Mater Dei hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Mater Dei has invested to date?As of June 2026, Mater Dei has invested in 1 company.
What was the last Mater Dei investment?On 24th September 2021 Mater Dei invested in Maria Saúde, participating in a $3M Seed round.
In what companies Mater Dei invested in?Mater Dei invested in Maria Saúde.

See public comps similar to Mater Dei

Lists including Mater Dei

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial